AllMind

The AI-powered financial markets research terminal for institutional investors.

Stay Updated

Cantor Fitzgerald initiates Milestone Pharmaceuticals stock coverage with overweight rating | AllMind AI News

Cantor Fitzgerald initiates Milestone Pharmaceuticals stock coverage with overweight rating

August 20, 2026

Article content was not accessible (HTTP 403), so no financial news details were available to analyze.

Article content was not accessible (HTTP 403), so no financial news details were available to analyze.

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Overall Sentiment

neutral

Sentiment Score

0.00

Wall Street Isn’t Buying Bessent Fix: Evening Briefing AmericasAugust 20, 2026
Broadcom Seeking $60B in AI Debt DealAugust 20, 2026
Housing Slump Winners and Losers, Australia Housing, Anthropic IPO PlanAugust 20, 2026
Applied Materials (AMAT) Q3 2026 Earnings Call TranscriptAugust 20, 2026
US pummels Cuban economy with new sanctions on mining, constructionAugust 20, 2026
Bessent's efforts in the Treasury market so far haven't worked. Here's what else he can tryAugust 20, 2026